Date

  Friday, June 30, 2023

Location

   Ballroom, Ritz Carlton Pacific Place

Mechanism

  Through electronic meeting via the eASY.KSEI platform and physical meeting with limited attendance. Physical attendance is limited to 100 people on a first-come, first-served basis due to maximum room capacity.

Time

  09:00 (GMT+7)

Agenda

   Annual General Meeting of Shareholders (AGMS):  

1. Approval of the Company’s annual report for the financial year 2022, which has been reviewed by the Board of Commissioners, including the ratification of the Company’s consolidated financial statements and its subsidiaries for the financial year ending on December 31, 2022, audited by the public accounting firm Purwantono, Sungkoro & Surja (a member firm of Ernst & Young Global Limited) and signed on March 31, 2023, along with the granting of full release and discharge (acquit et de charge) to all members of the Company’s Board of Directors and Board of Commissioners for the management and supervisory actions carried out during the financial year ending on December 31, 2022, as reflected in the Company’s annual report for the financial year 2022 and the consolidated financial statements of the Company and its subsidiaries for the financial year ending on December 31, 2022, which have been audited.  
2. Approval of the determination of salaries and allowances for the Board of Directors and the determination of honorarium and/or allowances for the Company’s Board of Commissioners for the financial year 2023.  
3. Approval to appoint an Independent Public Accountant to audit the Company’s consolidated financial statements for the financial year ending on December 31, 2023.  
4. Submission of a report on the realization of the use of funds from the Initial Public Offering.  
5. Approval of the renewal of the delegation of authority to the Board of Commissioners regarding the issuance of new shares in connection with the International Initial Public Offering.  
6. Approval of the renewal of the delegation of authority to the Board of Commissioners regarding the issuance of new shares to be granted to members of the Board of Directors, members of the Board of Commissioners, and/or employees of the Company and its subsidiaries based on the Share Ownership Program.  
7. Approval of the increase in capital without pre-emptive rights up to a maximum of 10% of the Company’s issued and paid-up capital (PMTHMETD).  
8. Approval of amendments to the Company’s Articles of Association in connection with the increase in issued and paid-up capital as the implementation of (i) the International IPO, (ii) the Share Ownership Program, and (iii) PMTHMETD.  
9. Approval of changes in the composition of the Company’s Board of Commissioners and Board of Directors. 

Extraordinary General Meeting of Shareholders (EGMS): 

1. Approval of independent shareholders for members of the Company’s Board of Directors who may become holders of Series B shares.